# SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis

> **NCT01010581** · PHASE2 · COMPLETED · sponsor: **4SC AG** · enrollment: 266 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** SC12267 (4SC-101)
- **DRUG:** Placebo
- **DRUG:** Methotrexate
- **DRUG:** Folic Acid

## Key facts

- **NCT ID:** NCT01010581
- **Lead sponsor:** 4SC AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-07
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2012-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010581, "SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01010581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*